Oyster Point Pharma OYST

$ 11.17 0.0%

Quarterly report 2022-Q3
added 11-10-2022

Oyster Point Pharma Balance Sheet 2011-2024 | OYST

Annual Balance Sheet Oyster Point Pharma

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-103 M	-192 M	-138 M	-5.17 M	-22.3 M	-	-	-	-	-	-
Long Term Debt	89.8 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	779 K	400 K	296 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	269 K	512 K	43 M	43 M	-	-	-	-	-	-
Total Current Liabilities	28.8 M	11 M	5.4 M	-	-	-	-	-	-	-	-
Total Liabilities	123 M	11.3 M	5.91 M	43.9 M	45.1 M	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-255 M	-155 M	-84.2 M	-38.5 M	-22 M	-	-	-	-	-	-
Total Assets	223 M	198 M	143 M	5.7 M	23.2 M	-	-	-	-	-	-
Cash and Cash Equivalents	193 M	193 M	139 M	5.23 M	-	-	-	-	-	-	-
Book Value	99.5 M	187 M	137 M	-38.2 M	-21.9 M	-	-	-	-	-	-
Total Shareholders Equity	99.5 M	187 M	137 M	-38.2 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Oyster Point Pharma

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	92.2 M	91.4 M	90.6 M	89.8 M	41.9 M	11 K	15 K	-	-	19 K	19 K	12 K	12 K	12 K	12 K	6 K	6 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	42.3 M	-	-	269 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	131 M	133 M	121 M	123 M	57.5 M	9.72 M	14.1 M	11.3 M	11.3 M	11.3 M	11.3 M	5.91 M	5.91 M	5.91 M	5.91 M	946 K	946 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-390 M	-353 M	-303 M	-255 M	-213 M	-196 M	-174 M	-155 M	-155 M	-155 M	-155 M	-84.2 M	-84.2 M	-84.2 M	-84.2 M	-38.5 M	-38.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	109 M	144 M	177 M	223 M	195 M	162 M	185 M	198 M	198 M	198 M	198 M	143 M	143 M	143 M	143 M	5.7 M	5.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	68.8 M	105 M	143 M	193 M	184 M	155 M	176 M	193 M	193 M	193 M	193 M	139 M	139 M	139 M	139 M	5.23 M	5.23 M	-	-	22.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-22.2 M	10.8 M	56 M	99.5 M	138 M	152 M	171 M	187 M	187 M	187 M	187 M	137 M	137 M	137 M	137 M	4.76 M	4.76 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-22.2 M	10.8 M	56 M	99.5 M	138 M	152 M	171 M	187 M	187 M	187 M	187 M	137 M	137 M	137 M	137 M	-38.2 M	-38.2 M	-27.7 M	-24.8 M	-21.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency